The pharmaceutical drug delivery market is expected to reach US$ 2,296,170.9 Mn in 2027 from US$ 1,403,082.9 Mn in 2019. The market is estimated to grow at a CAGR of 6.6% during 2020–2027.
Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients. Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular.
Lucrative Regional Markets for Pharmaceutical Drug Delivery
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
Growing Prevalence of Infectious and Chronic Diseases
The prevalence of infectious disease, especially bacterial diseases, is increasing continuously around the globe. According to a study published by American Society for Microbiology in 2019, the world reports ~1.5–4.5 million infections are caused by Carbapenem-resistant Enterobacteriaceae every year. Additionally, this group of bacteria also leads to the hospitalization of ~49,000 people in the US each year. Moreover, according to a study published by UNICEF, in 2018, pneumonia caused ~1,755,000 deaths of children with age <5; also, ~1,200,000 children in the word lost their lives by diarrhea. Such exponentially growing prevalence of infectious diseases drives the consumption of drugs, which eventually drives the pharmaceutical drug delivery market growth.
Among chronic conditions, cancer and diabetes are the leading cause of mortality worldwide. For instance, according to a study conducted by the American Cancer Society (ACS), the US reported ~1,735,350 new cancer cases in 2018. Further, according to the International Diabetes Federation (IDF), ~46 million Americans were suffering from diabetes in 2017, and this number is expected to reach 62 million by 2045. It has also mentioned that ~425 million people worldwide were living with diabetes in 2017, and the number is expected to reach 629 million by 2045.
Route of Administration Insights
The pharmaceutical drug delivery market, by route of administration, is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. The injectable drug delivery segment held the largest share of the market in 2019. However, the topical drug delivery segment is anticipated to register the highest CAGR in the market during the forecast period.
Pharmaceutical Drug Delivery Market, by Route of Administration – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Applications Insights
On the basis of applications, the pharmaceutical drug delivery market has been segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other diseases. The cancer segment held the largest share of the market in 2019; however, the infectious diseases segment is estimated to register the highest CAGR during the forecast period.
End User Insights
On the basis of end user, the pharmaceutical drug delivery market has been segmented into hospitals, home care settings, ASC/clinics, and other end users. The hospitals segment held the largest share of the market in 2019, whereas the home care settings segment is estimated to register the highest CAGR during 2020–2027.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Archive - Pharmaceutical Drug Delivery Market: Strategic Insights
Global Archive - Pharmaceutical Drug Delivery Market
-
CAGR (2019 - 2027)
6.6%
-
Market Size 2019
US$ 1,403.08 Billion
-
Market Size 2027
US$ 2,296.17 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- MERCK KGaA
- GlaxoSmithKline plc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory. Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Diseases
End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
Geography
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South and Central America
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Global Archive - Pharmaceutical Drug Delivery Market: Strategic Insights
-
CAGR (2019 - 2027)6.6% -
Market Size 2019
US$ 1,403.08 Billion -
Market Size 2027
US$ 2,296.17 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- MERCK KGaA
- GlaxoSmithKline plc.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory. Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Diseases
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- South and Central America
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Product launches and approvals is commonly adopted strategy by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players to expand their corresponding product portfolios.
The players operating in the pharmaceutical drug delivery market adopt the strategy of expansion to enlarge customer base across the world; they also implement the strategies of collaborations and product launches. These strategies permit them to maintain their brand name globally. For instance, in May 2018, GlaxoSmithKline plc received an FDA approval for the use of Arnuity Ellipta (fluticasone furoate) for the maintenance treatment of asthma in children below 5 years. It is a once-daily inhaled corticosteroid (ICS) medicine.
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Geography
North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
Asia Pacific (APAC)
- China
- India
- Japan
- South Korea
- Australia
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
South and Central America (SCAM)
- Brazil
- Argentina
Company Profiles
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- Merck KGaA
- GlaxoSmithKline plc.
- Antares Pharma
Global Archive - Pharmaceutical Drug Delivery Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 1,403.08 Billion |
Market Size by 2027 | US$ 2,296.17 Billion |
Global CAGR (2019 - 2027) | 6.6% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Route of Administration
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.
The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.
The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.
The List of Companies - Pharmaceutical Drug Delivery Market
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services, Inc.
- Novartis AG
- 3M
- Becton, Dickinson and Company
- Sanofi
- MERCK KGaA
- GlaxoSmithKline plc.
- Antares Pharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Global Archive - Pharmaceutical Drug Delivery Market
May 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)